Activation of NK cells is associated with HIV‐1 disease progression

The main predictor of HIV‐1 disease progression is CD8+ T cell activation, characterized by elevated expression of CD38 and HLA‐DR. NK cells are also activated in viremic HIV‐1‐infected individuals. However, the relationship between NK cell activation and HIV‐1 disease progression remains undefined. We characterized NK cell activation and its association with disease progression in treatment of naive HIV‐1‐infected individuals, who naturally maintained low/undetectable viremia (elite and viremic controllers), compared with progressors and AIDS subjects, and treated individuals. Our results show that CD38 expression on NK cells, predominantly in the cytotoxic CD56dimCD16+ subset, is associated with HIV‐1 disease progression (CD4+ T cell count and pVL), T cell activation (percentage of CD38+HLA‐DR+ T cells), sCD14, inflammation, and innate immune activation. Moreover, NK cell activation is increased in HIV‐1‐infected subjects progressing to AIDS but not in elite and viremic controllers. ART partially reduces the proportion of activated NK cells. Furthermore, our results show that individuals, who naturally control viremia, maintain low levels of innate immune activation similar to those of uninfected controls.

[1]  S. Boni,et al.  Natural killer cells in HIV controller patients express an activated effector phenotype and do not up-regulate NKp44 on IL-2 stimulation , 2013, Proceedings of the National Academy of Sciences.

[2]  M. Altfeld,et al.  Neither Microbial Translocation Nor TLR Responsiveness Are Likely Explanations for Preexisting Immune Activation in Women Who Subsequently Acquired HIV in CAPRISA 004 , 2013, Journal of acquired immune deficiency syndromes.

[3]  L. Moretta,et al.  Successfully treated HIV-infected patients have differential expression of NK cell receptors (NKp46 and NKp30) according to AIDS status at presentation. , 2013, Immunology letters.

[4]  M. Altfeld,et al.  Changes in Natural Killer Cell Activation and Function during Primary HIV-1 Infection , 2013, PloS one.

[5]  S. Rowland-Jones,et al.  The impact of HIV-1 infection and exposure on natural killer (NK) cell phenotype in Kenyan infants during the first year of life , 2012, Front. Immun..

[6]  M. Altfeld,et al.  Innate immune activation enhances hiv acquisition in women, diminishing the effectiveness of tenofovir microbicide gel. , 2012, The Journal of infectious diseases.

[7]  S. Lewin,et al.  Virologically Suppressed HIV Patients Show Activation of NK Cells and Persistent Innate Immune Activation , 2012, The Journal of Immunology.

[8]  A. Zolopa,et al.  Association of Low Level Viremia with Inflammation and Mortality in HIV-Infected Adults , 2011, PloS one.

[9]  Tracy L. Bergemann,et al.  Clinical Features and Serum Biomarkers in HIV Immune Reconstitution Inflammatory Syndrome after Cryptococcal Meningitis: A Prospective Cohort Study , 2010, PLoS medicine.

[10]  D. Jacobs,et al.  Markers of inflammation, coagulation, and renal function are elevated in adults with HIV infection. , 2010, The Journal of infectious diseases.

[11]  Rachel E. Owen,et al.  HIV+ elite controllers have low HIV-specific T-cell activation yet maintain strong, polyfunctional T-cell responses , 2010, AIDS.

[12]  A. Samri,et al.  Specific Phenotypic and Functional Features of Natural Killer Cells From HIV-Infected Long-Term Nonprogressors and HIV Controllers , 2010, Journal of acquired immune deficiency syndromes.

[13]  A. Moretta,et al.  Chronic HIV-1 viremia reverses NKG2A/NKG2C ratio on natural killer cells in patients with human cytomegalovirus co-infection , 2010, AIDS.

[14]  B. Agan,et al.  Clinical outcomes of elite controllers, viremic controllers, and long-term nonprogressors in the US Department of Defense HIV natural history study. , 2009, The Journal of infectious diseases.

[15]  M. Ballmaier,et al.  HIV Infection Is Associated with a Preferential Decline in Less-Differentiated CD56dim CD16+ NK Cells , 2009, Journal of Virology.

[16]  J. Margolick,et al.  Microbial translocation, the innate cytokine response, and HIV-1 disease progression in Africa , 2009, Proceedings of the National Academy of Sciences.

[17]  A. McMichael,et al.  Human CD4+ Memory T Cells Are Preferential Targets for Bystander Activation and Apoptosis1 , 2009, The Journal of Immunology.

[18]  Steven Patterson,et al.  Human NK Cell Up-regulation of CD69, HLA-DR, Interferon γ Secretion and Cytotoxic Activity by Plasmacytoid Dendritic Cells is Regulated through Overlapping but Different Pathways , 2009, Sensors.

[19]  B. Gazzard,et al.  Elevated plasma lipopolysaccharide is not sufficient to drive natural killer cell activation in HIV-1-infected individuals , 2009, AIDS.

[20]  C. Lewis,et al.  Association of antiretroviral therapy with fibrinogen levels in HIV-infection , 2008, AIDS.

[21]  Steven G. Deeks,et al.  HLA Class I-Restricted T-Cell Responses May Contribute to the Control of Human Immunodeficiency Virus Infection, but Such Responses Are Not Always Necessary for Long-Term Virus Control , 2008, Journal of Virology.

[22]  G. Silvestri,et al.  Immune activation and AIDS pathogenesis. , 2008, AIDS.

[23]  V. Appay,et al.  Immune activation and inflammation in HIV‐1 infection: causes and consequences , 2008, The Journal of pathology.

[24]  M. Altfeld,et al.  Single-Stranded RNA Derived from HIV-1 Serves as a Potent Activator of NK Cells1 , 2007, The Journal of Immunology.

[25]  P. Hunt.  Role of immune activation in HIV pathogenesis , 2007, Current HIV/AIDS reports.

[26]  J. Brenchley,et al.  Microbial translocation is a cause of systemic immune activation in chronic HIV infection , 2006, Retrovirology.

[27]  E. Rosenberg,et al.  Elite control of HIV infection: implications for vaccines , 2006, Retrovirology.

[28]  B. Gazzard,et al.  NKG2C+ NK Cells Are Enriched in AIDS Patients with Advanced-Stage Kaposi's Sarcoma , 2006, Journal of Virology.

[29]  R. Lempicki,et al.  Innate Immune Dysfunction in HIV Infection: Effect of HIV Envelope-NK Cell Interactions12 , 2006, The Journal of Immunology.

[30]  B. Lau,et al.  C-reactive protein is a marker for human immunodeficiency virus disease progression. , 2006, Archives of internal medicine.

[31]  A. Fauci,et al.  NK cells in HIV infection: paradigm for protection or targets for ambush , 2005, Nature Reviews Immunology.

[32]  Hendrik Streeck,et al.  Sequential deregulation of NK cell subset distribution and function starting in acute HIV-1 infection. , 2005, Blood.

[33]  B. Gazzard,et al.  Switch from inhibitory to activating NKG2 receptor expression in HIV-1 infection: lack of reversion with highly active antiretroviral therapy , 2005, AIDS.

[34]  A. Fauci,et al.  Characterization of CD56-/CD16+ natural killer (NK) cells: a highly dysfunctional NK subset expanded in HIV-infected viremic individuals. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[35]  D. Tough,et al.  Dendritic Cells and NK Cells Stimulate Bystander T Cell Activation in Response to TLR Agonists through Secretion of IFN-αβ and IFN-γ1 , 2005, The Journal of Immunology.

[36]  J. Hanna,et al.  Novel APC-like properties of human NK cells directly regulate T cell activation , 2015, bioRxiv.

[37]  Jessica M Malenfant,et al.  Increased Natural Killer Cell Activity in Viremic HIV-1 Infection1 , 2004, The Journal of Immunology.

[38]  Tao Dong,et al.  Immune Activation and CD8+ T-Cell Differentiation towards Senescence in HIV-1 Infection , 2004, PLoS biology.

[39]  B. Gazzard,et al.  Loss of the CD56hiCD16− NK cell subset and NK cell interferon‐γ production during antiretroviral therapy for HIV‐1: partial recovery by human growth hormone , 2003, Clinical and experimental immunology.

[40]  M. Daucher,et al.  Natural killer cells in HIV-1 infection: Dichotomous effects of viremia on inhibitory and activating receptors and their functional correlates , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[41]  L. Montaner,et al.  Sustained Impairment of IFN-γ Secretion in Suppressed HIV-Infected Patients Despite Mature NK Cell Recovery: Evidence for a Defective Reconstitution of Innate Immunity1 , 2002, The Journal of Immunology.

[42]  John W. Mellors,et al.  Predictive Value of Immunologic and Virologic Markers After Long or Short Duration of HIV‐1 Infection , 2002, Journal of acquired immune deficiency syndromes.

[43]  M. Robertson.  Role of chemokines in the biology of natural killer cells , 2002, Journal of leukocyte biology.

[44]  M. Caligiuri,et al.  The biology of human natural killer-cell subsets. , 2001, Trends in immunology.

[45]  C. Tacchetti,et al.  Signaling through CD38 induces NK cell activation. , 2001, International immunology.

[46]  U. Dianzani,et al.  Role of CD38 in HIV-1 infection: an epiphenomenon of T-cell activation or an active player in virus/host interactions? , 2000, AIDS.

[47]  Solana,et al.  CD69 is a stimulatory receptor for natural killer cell and its cytotoxic effect is blocked by CD94 inhibitory receptor , 1999, Immunology.

[48]  J V Giorgi,et al.  Shorter survival in advanced human immunodeficiency virus type 1 infection is more closely associated with T lymphocyte activation than with plasma virus burden or virus chemokine coreceptor usage. , 1999, The Journal of infectious diseases.

[49]  F. Malavasi,et al.  Human CD38, a cell‐surface protein with multiple functions , 1996, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[50]  C. Mela,et al.  The contribution of cytomegalovirus to changes in NK cell receptor expression in HIV-1-infected individuals. , 2007, The Journal of infectious diseases.

[51]  C. Sheasby.  Dendritic Cells and NK Cells Stimulate Bystander T Cell Activation in Response to TLR Agonists through Secretion of IFN- and IFN- , 2004 .